Active Management of Labour in Parous Women (Fetomaternal Effect)

Hayfa Al-Shaheen

doi:10.33762/bsurg.2003.55288

Abstract

This prospective study was carried out during nine months period (first of December 2000 until the end of August 2001) in Basrah Maternity and Children Hospital to evaluate whether oxytocin augmentation would shorten the length of labour, lower cesarean section rate or has any adverse effects on neonatal outcome. Data were collected and analyzed on 506 low risk multiparous (p1-3), at term, in spontanous labour. Two hundred forty nine of them needed oxytocin augmentation while 257 had spontaneous effective uterine contractions. This study confirmed that the mean duration of first stage of labour in oxytocin augmented patients shortened by 1.3 hours (from 5.8 hours in control to 4.5 hours in oxytocin augmented women), p value

Highlights

During the past 20 years of obstetric practice in the United States, there has been an alarming increase in the rate of cesarean deliveries
The aim of the study is to evaluate the efficacy of oxytocin augmentation in multigravda labour in order to clarify whether active management of labour would shorten labour, affect rate of caesarean section and operative vaginal delivery, whether it has any adverse effects on neonatal outcome, and to improve maternal and fetal safety if oxytocin is used as apart of protocol active management[4]
This study is a prospective case-control study that was conducted in Basrah Maternity and Children Hospital from the first of December 2000 until the end of August 2001

Summary

Introduction

During the past 20 years of obstetric practice in the United States, there has been an alarming increase in the rate of cesarean deliveries. A labour which is unduly prolonged is likely to give rise to one or more of three types of distress, namely maternal, fetal or obstetricians distress[3] It presents a picture of mental anguish and physical morbidity which often leads to surgical intervention and may produce a permanent revulsion to child birth, expressed by the mother as voluntary infertility; it constitutes as danger to the survival and subsequent neurological development of the infant. The aim of the study is to evaluate the efficacy of oxytocin augmentation in multigravda labour in order to clarify whether active management of labour would shorten labour, affect rate of caesarean section and operative vaginal delivery, whether it has any adverse effects on neonatal outcome, and to improve maternal and fetal safety if oxytocin is used as apart of protocol active management[4]

Objectives

Methods

Results

Discussion

Conclusion